Matches in Wikidata for { <http://www.wikidata.org/entity/Q57068131> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- Q57068131 description "article scientifique publié en 2018" @default.
- Q57068131 description "artículu científicu espublizáu en setiembre de 2018" @default.
- Q57068131 description "im September 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q57068131 description "scientific article published on 27 September 2018" @default.
- Q57068131 description "wetenschappelijk artikel" @default.
- Q57068131 description "наукова стаття, опублікована у вересні 2018" @default.
- Q57068131 name "Corrigendum to 'Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update" @default.
- Q57068131 name "Corrigendum to 'Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk" @default.
- Q57068131 type Item @default.
- Q57068131 label "Corrigendum to 'Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update" @default.
- Q57068131 label "Corrigendum to 'Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk" @default.
- Q57068131 prefLabel "Corrigendum to 'Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update" @default.
- Q57068131 prefLabel "Corrigendum to 'Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk" @default.
- Q57068131 P1433 Q57068131-3ED58AE4-A3C5-4484-AD1B-99379B74A3D4 @default.
- Q57068131 P1476 Q57068131-78B5C7E5-C392-46ED-90BA-673E5BFF13AD @default.
- Q57068131 P2093 Q57068131-00ABC128-7E0A-4B58-A5EC-2703B80B4F1C @default.
- Q57068131 P2093 Q57068131-058CD13E-F6CA-437C-9283-961083C567D4 @default.
- Q57068131 P2093 Q57068131-137189BF-2AF6-441F-9534-4E52CFC4A0E9 @default.
- Q57068131 P2093 Q57068131-40086937-E899-46E1-B291-353C7BB535C6 @default.
- Q57068131 P2093 Q57068131-4E223AC4-8D1C-4901-8F11-6E55243DE535 @default.
- Q57068131 P2093 Q57068131-629FEFCB-7A1A-48C9-9F99-2247F0DE7C73 @default.
- Q57068131 P2093 Q57068131-65FFD159-DA32-49D2-9A9C-1A29B83CA84F @default.
- Q57068131 P2093 Q57068131-828F39A7-0090-4E49-8B5F-EE67EEB25895 @default.
- Q57068131 P2093 Q57068131-8BFD9A33-2942-46EF-B5C8-5C42932E7F48 @default.
- Q57068131 P2093 Q57068131-B38A9575-7AB9-4F40-B288-6D5DB2532450 @default.
- Q57068131 P2093 Q57068131-B8263AD7-04D2-44B8-A3AC-FD58499D35EC @default.
- Q57068131 P2093 Q57068131-BA1831BE-D49F-4D5D-833F-4878EC1FAE82 @default.
- Q57068131 P2093 Q57068131-D906E435-3DBC-4ABA-AA60-02CF0F2072A2 @default.
- Q57068131 P2093 Q57068131-FE794792-0B34-4808-9972-15912D5B3894 @default.
- Q57068131 P304 Q57068131-1CC5B108-948B-4A15-A19A-CBCE42032BE4 @default.
- Q57068131 P31 Q57068131-18039AB9-7D1B-407E-82F7-F2185496EC2F @default.
- Q57068131 P31 Q57068131-28BEA193-8B49-470B-8E69-41849B9214DC @default.
- Q57068131 P356 Q57068131-07902727-F39F-455F-8D38-48947EC17562 @default.
- Q57068131 P407 Q57068131-05286A84-9B6A-4DF8-87D2-8BAD828E9963 @default.
- Q57068131 P478 Q57068131-6BB04DB5-0A97-4F25-86BD-A305E2A0FD86 @default.
- Q57068131 P50 Q57068131-BBCCB710-5DCB-47E0-96A9-69161EBED3AD @default.
- Q57068131 P50 Q57068131-DDF14B29-D098-4045-9278-0E68072FAA1F @default.
- Q57068131 P577 Q57068131-868E59EA-525C-4463-8C4B-D98D4A111482 @default.
- Q57068131 P698 Q57068131-52DF207B-0F64-4706-9552-648D1A114A51 @default.
- Q57068131 P921 Q57068131-5F423BD9-18B9-4540-9796-DBBFF07A7BE9 @default.
- Q57068131 P921 Q57068131-DDFAF7CB-6BB8-421A-97AD-E335C8221FD3 @default.
- Q57068131 P932 Q57068131-FE414096-C317-4D1D-8D10-EA8BC44F1E00 @default.
- Q57068131 P356 J.EJCA.2018.09.022 @default.
- Q57068131 P698 30270112 @default.
- Q57068131 P1433 Q332260 @default.
- Q57068131 P1476 "Corrigendum to 'Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update' [Eur J Cancer 94 (May 2018) 115-125]" @default.
- Q57068131 P2093 "Ben Sanford" @default.
- Q57068131 P2093 "Christian Scheffold" @default.
- Q57068131 P2093 "Colin Hessel" @default.
- Q57068131 P2093 "Daniel George" @default.
- Q57068131 P2093 "Darren R Feldman" @default.
- Q57068131 P2093 "Eric J Small" @default.
- Q57068131 P2093 "Joel Picus" @default.
- Q57068131 P2093 "M Dror Michaelson" @default.
- Q57068131 P2093 "Meghara Walsh" @default.
- Q57068131 P2093 "Michael J Morris" @default.
- Q57068131 P2093 "Milan Mangeshkar" @default.
- Q57068131 P2093 "Olwen Hahn" @default.
- Q57068131 P2093 "Shaker Dakhil" @default.
- Q57068131 P2093 "Thomas Olencki" @default.
- Q57068131 P304 "287" @default.
- Q57068131 P31 Q13442814 @default.
- Q57068131 P31 Q1348305 @default.
- Q57068131 P356 "10.1016/J.EJCA.2018.09.022" @default.
- Q57068131 P407 Q1860 @default.
- Q57068131 P478 "103" @default.
- Q57068131 P50 Q42896002 @default.
- Q57068131 P50 Q88414622 @default.
- Q57068131 P577 "2018-09-27T00:00:00Z" @default.
- Q57068131 P698 "30270112" @default.
- Q57068131 P921 Q1164529 @default.
- Q57068131 P921 Q19000948 @default.
- Q57068131 P932 "6299293" @default.